Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Lululemon expects Q4 results at top end after strong festive sales

Mon 12 Jan 2026 13:42

(Sharecast News) - Shares in Lululemon were rising on Wall Street on Monday after the Canadian upmarket athleisure brand said results would be at the top end of forecasts following a strong festive selling season. The Vancouver-based workout and lifestyle clothing manufacturer said net revenues and diluted earnings per share for the fourth quarter to 2 February are now expected to be at the "high end" of guided ranges.

The firm had previously guided to net revenues of $3.500bn-3.585bn and earnings per share of $4.66-4.76, down from $3.60bn and $6.14 reported the year before respectively.

"Based on our performance over the holiday period, we expect to achieve the higher end of our previously communicated fourth quarter net revenue and EPS guidance," said chief financial officer Meghan Frank.

"We remain focused on executing our action plan to drive improvement in our U.S. business and look forward to the opportunities in front of us."

The update comes ahead of Lululemon management meeting with analysts ant investors at the annual consumer insights event, the ICR Conference, taking place in Orlando this week.

Lululemon shares were up nearly 2% at $207.75 by 1538 GMT.

Share this article

Related Sharecast Articles

Thu 15 Oct 2026 13:51
Culture Secretary 'minded to intervene' in Sky-ITV deal
(Sharecast News) - Culture secretary Lisa Nandy on Thursday revealed that she is "minded to intervene" in Sky's proposed takeover of ITV's media and entertainment activities, suggesting possible legislation of the streaming industry may be needed.
Thu 15 Oct 2026 13:49
AstraZeneca enters into strategic drug discovery deal with AI biotech Insitro
(Sharecast News) - AstraZeneca said on Thursday that it will pay up to $1.86bn to enter a new strategic drug discovery collaboration and licensing agreement with Califiornia-based AI biotech firm Insitro.
Thu 15 Oct 2026 12:10
BNY beats forecasts as quarterly profits jump 20%
(Sharecast News) - The Bank of New York Mellon reported double-digit growth in third-quarter revenues and profits on Thursday, beating market expectations as higher client activity, new business and rising asset values boosted performance.
Thu 15 Oct 2026 12:08
Berenberg lifts target price on Discoverie following H1 update
(Sharecast News) - Analysts at Berenberg lifted their target price for DiscoverIE from 1,050p to 1,100p on Thursday, citing sustained organic momentum, a strengthening order book and earnings running ahead of expectations.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Awards

Award 1
Award 2
Award 3

Policies and important information

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statements | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Statutory and Regulatory disclosures | Whistleblowing programme

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026